Range Low Price High Price Comment
30 days $28.00 $28.00 Tuesday, 30th Apr 2024 AMAM stock ended at $28.00. During the day the stock fluctuated 0% from a day low at $28.00 to a day high of $28.00.
90 days $27.61 $28.00
52 weeks $6.56 $28.15

Historical Ambrx Biopharma Inc. prices

Date Open High Low Close Volume
Apr 30, 2024 $28.00 $28.00 $28.00 $28.00 0
Apr 29, 2024 $28.00 $28.00 $28.00 $28.00 0
Apr 26, 2024 $28.00 $28.00 $28.00 $28.00 0
Apr 25, 2024 $28.00 $28.00 $28.00 $28.00 0
Apr 24, 2024 $28.00 $28.00 $28.00 $28.00 0
Apr 23, 2024 $28.00 $28.00 $28.00 $28.00 0
Apr 22, 2024 $28.00 $28.00 $28.00 $28.00 0
Apr 19, 2024 $28.00 $28.00 $28.00 $28.00 0
Apr 18, 2024 $28.00 $28.00 $28.00 $28.00 0
Apr 17, 2024 $28.00 $28.00 $28.00 $28.00 0
Apr 16, 2024 $28.00 $28.00 $28.00 $28.00 0
Apr 15, 2024 $28.00 $28.00 $28.00 $28.00 0
Apr 11, 2024 $28.00 $28.00 $28.00 $28.00 0
Apr 10, 2024 $28.00 $28.00 $28.00 $28.00 0
Apr 09, 2024 $28.00 $28.00 $28.00 $28.00 0
Apr 08, 2024 $28.00 $28.00 $28.00 $28.00 0
Apr 05, 2024 $28.00 $28.00 $28.00 $28.00 0
Apr 04, 2024 $28.00 $28.00 $28.00 $28.00 0
Apr 03, 2024 $28.00 $28.00 $28.00 $28.00 0
Apr 02, 2024 $28.00 $28.00 $28.00 $28.00 0
Apr 01, 2024 $28.00 $28.00 $28.00 $28.00 0
Mar 28, 2024 $28.00 $28.00 $28.00 $28.00 0
Mar 27, 2024 $28.00 $28.00 $28.00 $28.00 0
Mar 26, 2024 $28.00 $28.00 $28.00 $28.00 0
Mar 25, 2024 $28.00 $28.00 $28.00 $28.00 0
Click to get the best stock tips daily for free!

About Ambrx Biopharma Inc.

Ambrx Biopharma. Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gastric/gastroesophageal junction cancer, and other solid tumors, including ongoing Phase 2/3 clinical tri... AMAM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT